0001209191-21-052398.txt : 20210818
0001209191-21-052398.hdr.sgml : 20210818
20210818191132
ACCESSION NUMBER: 0001209191-21-052398
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210816
FILED AS OF DATE: 20210818
DATE AS OF CHANGE: 20210818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Janssen Robert
CENTRAL INDEX KEY: 0001580849
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 211187910
MAIL ADDRESS:
STREET 1: C/O DYNAVAX TECHNOLOGIES
STREET 2: 2929 SEVENTH STREET, SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 900
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 900
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-16
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001580849
Janssen Robert
C/O DYNAVAX TECHNOLOGIES
2100 POWELL STREET, SUITE 900
EMERYVILLE
CA
94608
0
1
0
0
Senior Vice President
Common Stock
2021-08-13
4
A
0
1415
3.3915
A
8276
D
Common Stock
2021-08-16
4
M
0
2917
5.42
A
11193
D
Common Stock
2021-08-16
4
S
0
2917
12.36
D
8276
D
Stock Option (Right to Buy)
5.42
2021-08-16
4
M
0
2917
D
2027-02-11
Common Stock
2917
52500
D
Represents 1,415 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on August 13, 2021.
The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on August 11, 2020.
This transaction was executed in multiple trades at prices ranging from $12.00 to $12.73; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter.
Not applicable
/s/ Robert Janssen
2021-08-18